Treatment Methods for Early and Advanced Prostate Cancer

Roger S. Kirby, Alan Partin, J. Kellogg Parsons, Mark Feneley

Section A: General Considerations Affecting Treatment Options for Patients with Prostate Cancer 1. Mortality trends in prostate cancer 2. Decision-making for men with prostate cancer 3. Practical and realistic lifestyle changes and supplements for the man concerned about prostate cancer: what do I tell my patients 4. Preservation of sexual function in prostate cancer treatment 5. Quality of life instruments for prostate cancer Section B: Treatment Options for localised prostate cancer 6. Comparison of treatment modalities for prostate cancer by quality of life instruments 7. Natural history and expectant management of prostate cancer 8. Clinical trials comparing expectant management to definitive treatment of prostate cancer (PIVOT, Holmberg, PROTECT, etc.) 9. Anatomical considerations of radical prosptatectomy 10. Anatomic radical retropubic prostatectomy 11. Radical retropubic prostatectomy: contemporary modifications 12. The role of lymphadenectomy in prostate cancer 13. Clinical management of rising prostate specific antigen after radical retropubic prostatectomy 14. Radical perineal prostatectomy 15. Laparoscopic and robotic radical prostatectomy 16. Vattikuti Institute Prostatectomy 17. Making the transition from open to roboticlly assisted radical prostatectomy 18. Initial management of high risk early stage prostate cancer: surgery 19. Prevention And Management Of Complications Associated With Open Radical Retropubic Prostatectomy 20. External beam radiotherapy for the treatment of prostate cancer 21. Brachytherapy for the treatment of prostate cancer 22. High dose rate as monotherapy or as a boost: the new prostate brachytherapy 23. Magnetic resonance image-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate 24. Hyperthermia for treatment of localized prostate cancer 25. Initial management of high risk early stage prostate cancer: radiation 26. Management of biochemical recurrence following radiation therapy 27. Cryotherapy as primary therapy for localised prostate cancer 28. Cryotherapy as salvage therapy for prostate cancer 29. Neoadjuvant and adjuvant hormonal therapies for prostate cancer: data review and patient perspectives 30. The assessment and management of urinary incontinence in patients with prostate cancer 31. Rehabilitation of sexual function following definitive treatment of local prostate cancer 32. The limitations of evidence based comparisons of treatment for localized prostate cancer 33. Choosing prostate cancer treatment: The clinician as patient 34. Coping with a diagnosis of prostate cancer: A patient’s perspective Section C: Treatment of Locally Advanced and Metastatic Prostate Cancer 35. Androgen deprivation for the treatment of prostate cancer: General principles 36. Hormone therapy for prostate cancer: Optimization and timing 37. Controversies in hormone treatment for prostate cancer 38. Androgen deprivation for prostate cancer: Future directions 39. Intermittent hormone therapy for prostate cancer 40. Anti-androgen withdrawal syndrome: Identification and treatment 41. Chemotherapy for advanced prostate cancer 42. Radiotherapy for the treatment of locally advanced and metastatic prostate cancer 43. Use of bisphosphonates in the management of osseous metastases 44. Management of complications of advanced prostate cancer 45. Principles of palliative care and psychosocial support of the metastatic prostate cancer patient 46. Future directions for treatment of advanced prostate cancer: Gene therapy and other novel modalities 47. The increasing role of the primary care professional in the care of the prostate cancer patient